Tonix Pharm Holdings (TNXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -93,715 | -14,939 | -116,658 | -89,336 | -61,361 |
| Depreciation Amortization | 2,846 | 1,512 | 4,291 | 3,030 | 1,814 |
| Accounts receivable | -3,339 | N/A | N/A | -1,562 | N/A |
| Accounts payable and accrued liabilities | 6,703 | 2,976 | -3,490 | 446 | -571 |
| Other Working Capital | 5,984 | 1,165 | -35 | -398 | -1,889 |
| Other Operating Activity | 54,027 | -8,289 | 13,889 | 8,157 | 5,729 |
| Operating Cash Flow | $-27,494 | $-17,575 | $-102,003 | $-79,663 | $-56,278 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -108 | -108 | -6,896 | -6,465 | -5,644 |
| Net Acquisitions | N/A | N/A | -22,174 | -22,174 | -22,174 |
| Investing Cash Flow | $-108 | $-108 | $-29,070 | $-28,639 | $-27,818 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 8,942 | N/A | N/A |
| Common Stock Issued | 10,753 | 23 | 41,540 | 9,768 | 3,494 |
| Common Stock Repurchased | N/A | N/A | -13,965 | -13,965 | -13,965 |
| Other Financing Activity | -3,940 | -235 | 0 | 0 | 0 |
| Financing Cash Flow | $6,813 | $-212 | $36,517 | $-4,197 | $-10,471 |
| Exchange Rate Effect | -3 | -4 | -65 | -55 | -43 |
| Beginning Cash Position | 25,850 | 25,850 | 120,470 | 120,470 | 120,470 |
| End Cash Position | 5,058 | 7,951 | 25,849 | 7,916 | 25,860 |
| Net Cash Flow | $-20,792 | $-17,899 | $-94,621 | $-112,554 | $-94,610 |
| Free Cash Flow | |||||
| Operating Cash Flow | -27,494 | -17,575 | -102,003 | -79,663 | -56,278 |
| Capital Expenditure | -108 | -108 | -7,895 | -7,457 | -5,644 |
| Free Cash Flow | -27,602 | -17,683 | -109,898 | -87,120 | -61,922 |